India has earned its reputation as the "Pharmacy of the World" by producing high-quality generic medicines at a fraction of the cost charged in developed countries. For international buyers —…
Sun Pharmaceutical Industries, India’s largest drugmaker, has received approval from the South African Health Products Regulatory Authority (SAHPRA) to market a generic version of semaglutide injection. The approval marks a…
One of the most common questions international buyers ask about Indian generic medicines is: "How do I know the quality is real?" The answer lies in the rigorous, multi-stage laboratory…
The landmark India-UK Comprehensive Economic Trade Agreement (CETA) came into effect on July 15, 2026, marking a new chapter for Indian pharmaceutical exports to Britain. The Pharmaceutical Export Promotion Council…